# Evaxion (EVAX) — News

EVAX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/evax/news

## Recent headlines

- [EVAXION will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 annual meeting](https://www.ainvest.com/news/evaxion-present-immune-data-personalized-cancer-vaccine-evx-01-sitc-2026-annual-meeting-2610) — AInvest Wire, Oct 2, 2026
- [Evaxion Q2 basic EPS USD -0.01](https://www.ainvest.com/news/evaxion-q2-basic-eps-usd-0-01-2608) — AInvest Wire, Aug 20, 2026
  Evaxion A/S (NASDAQ: EVAX) reported a basic and diluted earnings per share (EPS) of -$0.12 for the second quarter of 2024, reflecting continued net loss for the clinical-stage biotechnology firm. This performance aligns with the company’s ongoing investment in its AI-Immunology™ platform and…
- [Evaxion Q2 pretax profit USD -3.933 million](https://www.ainvest.com/news/evaxion-q2-pretax-profit-usd-3-933-million-2608) — AInvest Wire, Aug 20, 2026
- [Evaxion Q2 operating income USD -3.846 million](https://www.ainvest.com/news/evaxion-q2-operating-income-usd-3-846-million-2608) — AInvest Wire, Aug 20, 2026
- [Evaxion announces business update and second quarter 2026 financial results](https://www.ainvest.com/news/evaxion-announces-business-update-quarter-2026-financial-results-2608) — AInvest Wire, Aug 20, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).